Study Title
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men With Metastatic Castration-Resistant Prostate Cancer
Study Details
Description:
This clinical trial will evaluate the safety of Radium-223 in combination with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: Phase I/II study
Sponsor:
Peter MacCallum Cancer Centre
Contacts:
Gaurav Sharmagaurav.sharma@petermac.org
03 85596830
Dr Louise Kostos, MBBS, FRACPlouise.kostos@petermac.org
Prof Michael Hofman (Principal Investigator)null
null
Government Study Link:
NCT05383079 - Click here to see study onClinicalTrials.gov